We are live on ! Find out more
CCM

Cadian Capital Management Portfolio holdings

AUM $821M
1-Year Est. Return 14.36%
This Fund
S&P 500
This Quarter Est. Return
-7.82%
1 Year Est. Return
-14.36%
3 Year Est. Return
+4.6%
5 Year Est. Return
+8.64%
10 Year Est. Return
+282.79%
AUM
$2.1B
AUM Growth
-$114M
Cap. Flow
+$99M
Cap. Flow %
4.71%
Top 10 Hldgs %
73.32%
Holding
32
New
4
Increased
10
Reduced
9
Closed
6

Sector Composition

Rank Sector Weight
1 Technology 42.05%
2 Communication Services 28.01%
3 Healthcare 19.82%
4 Consumer Discretionary 2.8%
5 Industrials 0.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPLI
1
People Inc
PPLI
$3.12B
$332M 15.78%
8,519,332
+893,911
+12% +$38.2M
PANW icon
2
Palo Alto Networks
PANW
$256B
$259M 12.33%
7,636,896
-273,000
-3% -$9.66M
ZNGA
3
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
$166M 7.88%
28,493,500
+7,668,463
+37% +$46.1M
ZGNX
4
DELISTED
Zogenix, Inc.
ZGNX
$139M 6.61%
3,473,695
+188,285
+6% +$8.68M
SPOT icon
5
Spotify
SPOT
$108B
$129M 6.12%
1,130,000
-19,422
-2% -$2.74M
VRNS icon
6
Varonis Systems
VRNS
$4.67B
$113M 5.39%
5,687,973
+2,719,314
+92% +$60.5M
BPMC
7
DELISTED
Blueprint Medicines
BPMC
$104M 4.96%
1,418,704
+895,443
+171% +$77.4M
RDWR icon
8
Radware
RDWR
$983M
$103M 4.88%
4,232,009
-101,140
-2% -$2.53M
PEGA icon
9
Pegasystems
PEGA
$5.09B
$98.8M 4.7%
2,903,026
-43,374
-1% -$1.57M
PTLA
10
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$98.3M 4.68%
3,667,037
-424,650
-10% -$11.9M
SRPT icon
11
Sarepta Therapeutics
SRPT
$1.64B
$94.3M 4.48%
1,252,500
+704,000
+128% +$83.1M
ZEN
12
DELISTED
ZENDESK INC
ZEN
$77.4M 3.68%
+1,061,400
New +$87.4M
BKNG icon
13
Booking.com
BKNG
$156B
$58.9M 2.8%
750,000
GWRE icon
14
Guidewire Software
GWRE
$13.9B
$58.6M 2.79%
556,096
+62,396
+13% +$6.29M
NSTG
15
DELISTED
NanoString Technologies, Inc.
NSTG
$53.5M 2.54%
2,476,069
+948,860
+62% +$25.2M
NBIS
16
Nebius Group N.V.
NBIS
$37.6B
$48M 2.28%
1,370,000
-1,895,000
-58% -$71.5M
CHTR icon
17
Charter Communications
CHTR
$17.3B
$45.3M 2.16%
110,000
-90,000
-45% -$36.3M
GNMK
18
DELISTED
GenMark Diagnostics, Inc
GNMK
$34.2M 1.63%
5,643,118
+2,370
+0% +$14.8K
EB
19
DELISTED
Eventbrite
EB
$27.2M 1.29%
+1,535,000
New +$26.9M
HHR
20
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$17.6M 0.83%
910,000
CVS icon
21
CVS Health
CVS
$135B
$12.6M 0.6%
200,000
SAIL
22
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$8.58M 0.41%
+459,000
New +$9.74M
FOLD
23
DELISTED
Amicus Therapeutics
FOLD
$8.02M 0.38%
1,000,000
+400,000
+67% +$4.34M
META icon
24
Meta Platforms (Facebook)
META
$1.49T
$8.01M 0.38%
45,000
-455,000
-91% -$86.5M
EOLS icon
25
Evolus
EOLS
$397M
$5.22M 0.25%
+334,396
New +$5.48M

Similar funds

Cadian Capital Management's Q3 2019 Portfolio in Review

As of Q3 2019, Cadian Capital Management held 32 positions worth $2.1B, down 5.2% from $2.22B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Cadian Capital Management deployed $99M of net new capital in Q3 2019, opening 4 new positions and adding to 10 existing holdings. Its largest new stake was ZENDESK INC: 1,061,400 shares worth $77.4M.

By sector, the portfolio is most concentrated in Technology at 42% of assets, up from 34% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $86.5M trimmed.

  • Cadian Capital Management's largest Q3 2019 buy was ZENDESK INC: 1,061,400 shares worth $77.4M.
  • Cadian Capital Management added most to Sarepta Therapeutics in Q3 2019, an estimated $83.1M increase.
  • Cadian Capital Management's biggest Q3 2019 reduction was Meta Platforms (Facebook), cutting an estimated $86.5M.
  • Cadian Capital Management fully exited Netflix in Q3 2019, selling an estimated $64.3M.
  • Cadian Capital Management's ten largest holdings make up 73% of its $2.1B portfolio in Q3 2019.
  • Cadian Capital Management opened 4 new positions and closed 6 in Q3 2019.
  • Cadian Capital Management's portfolio value fell 5.2% quarter-over-quarter to $2.1B.

Based on Cadian Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.